AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹4.93 Cr | ₹5.68 Cr | ₹11 Cr | ₹47 Cr | ₹29 Cr |
What is the latest Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹4.93 Cr |
| Mar2025 | ₹5.68 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹47 Cr |
| Mar2022 | ₹29 Cr |
How is Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.93 Cr | -13.20 | |
| Mar2025 | ₹5.68 Cr | -50.37 | |
| Mar2024 | ₹11 Cr | -75.76 | |
| Mar2023 | ₹47 Cr | 60.86 | |
| Mar2022 | ₹29 Cr | - | |
Compare Consolidated Net Profit of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹238.2 Cr | -5% | -9.6% | -13.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -5% |
-9.6% |
-13.8% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses